The subdued stock price reaction suggests that The Cigna Group's (NYSE:CI) strong earnings didn't offer any surprises. Our analysis suggests that investors might be missing some promising details.

In other recent news, Cigna Corporation reported strong first-quarter 2025 earnings, with an adjusted earnings per share (EPS) of $6.74, surpassing the consensus estimate of $6.35.

Rice provided insights following a recent investor event at the Evernorth Innovation Lab, hosted alongside Cigna management. According to InvestingPro data, the company currently trades at $315.99, ...

As Trump's sweeping tax-cut and spending bill marches forward, analysts examine how his broad-ranging policies could turn the ...

Hims & Hers Health, Inc. navigates strong growth and partnerships despite rising competitive risks. Click here to read an analysis of HIMS stock now.

In Medicare Advantage, UnitedHealth holds a firm advantage, having increased its market share from 25% in 2017 to 29% in 2023. For comparison, Humana (NYSE: HUM) holds 18% market share in both periods ...

Boards have increasingly benchmarked against peers as companies release more detailed pay data, per the research.

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was ...

CVS is trading at a trailing 12-month price-to-earnings, a commonly used multiple for valuing healthcare stocks, of 9.65X, ...

Image Source: Silkcharts Meanwhile, Cigna stock’s gain reflects the strong performance of the Evernorth Health Services segment, driven by specialty pharmacy, biosimilars and pharmacy benefit ...

On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE: CI) with a price target of $390.